F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review the facility failed to reconcile, dispose, and account for a
discontinued controlled medication (medications that are regulated by the government due to the likelihood
for being misused and high risk for abuse) to prevent drug diversion (the illegal distribution or abuse of
prescription drugs) for one resident (Resident 1).
As a result of this deficient practice, six tablets of the controlled medication went missing, and there was an
inaccurate count of the controlled medication.
Findings:
Resident 1 was re-admitted to the facility on [DATE] with the diagnoses including chronic respiratory failure
with hypoxia (a condition where there is not enough oxygen in the body) and dependence on ventilator
(breathing machines that keep lungs working) according to the facility's admission Record.
An abbreviated survey for a facility reported incident was conducted on 11/16/23.
During an interview and concurrent observation with the Assistant Director of Nursing (ADON) on 11/16/23,
at 9:20 A.M., the ADON showed a large, white container in the medication room. The ADON stated
non-controlled medications (medications prescribed by a physician and over the counter medications) were
disposed in the container and sealed once full. The ADON further stated controlled medications were given
to the Director of Nursing (DON) for disposal. The ADON then went to the DON's office and the DON
showed a locked drawer. The DON unlocked the drawer, and it contained one card of Alprazolam 0.5
milligrams (mg) labeled with Resident 1's name.
The medication count sheet titled, Controlled Drug Record, was reviewed with the DON. The count sheet
did not have signatures under dose given, but had two signatures dated 7/6/23, indicating 30 doses were
received.
During an observation of Resident 1 on 11/6/23, at 9:27 A.M., Resident 1 was in bed with eyes closed.
Resident 1 was observed with a tracheostomy (an opening on the neck with a tube to help with breathing)
connected to a ventilator.
An interview and concurrent record review was conducted with Licensed Nurse (LN) 1 on 11/16/23, at
10:43 A.M. LN1 stated discontinued controlled medications were counted and compared with the count
sheet to ensure accuracy. LN 1 stated any inaccuracies were reported to the DON. LN 1 stated
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
555871
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555871
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/08/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Somerset Subacute and Care
151 Claydelle Ave
El Cajon, CA 92020
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
controlled medications were given to the DON for disposal. LN 1 checked Resident 1's medication
administration record with LN 3. LN 1 and LN 3 confirmed that Resident 1 did not receive Alprazolam for
the months of October and November this year (2023) because the medication was already discontinued.
During an interview on 11/16/23, at 10:50 A.M., with LN 2, LN 2 stated discontinued controlled medication
were logged in a binder in the DON's office and handed to the DON personally for disposal.
An interview was conducted on 11/16/23, at 1:59 P.M., with LN 5. LN 5 stated on 11/9/23 he witnessed LN
6 in the medication room holding a controlled medication card for disposal. LN 5 informed LN 6 that
controlled medications were to be given to the DON. LN 5 stated he notified the charge nurse (LN 4) of the
incident.
An interview was conducted on 11/16/23, at 4:23 P.M., with LN 4. LN 4 stated as he was going to the
medication room, LN 6 was heading towards the medication cart. LN 4 stated LN 6 handed the medication
card with Resident 1's name, observed 24 tablets of Alprazolam on the card, and the count sheet had 30
tablets remaining. LN 4 stated LN 6 indicated there was another medication card that was disposed in the
trash. LN 6 was not able to identify which trash can the medication card was disposed. LN 4 stated all trash
cans and outside dumpster were searched and there was no other medication card found.
During an interview on 11/16/23, at 12:05 P.M., with the ADON, the ADON stated Resident 1 was
re-admitted on [DATE] and did not have an order for the controlled medication (Alprazolam).
An interview was conducted on 12/4/23, at 4:48 P.M., with the facility's pharmacist. The pharmacist stated it
was his expectation for licensed nurses to give discontinued controlled medications to the DON as soon as
possible to prevent drug diversion.
During an interview on 12/8/23, at10:18 A.M., with the DON, the DON acknowledged the discontinued
controlled medication should not be in the medication cart due to the risk of diversion.
A review of the facility's undated policy and procedure (P&P) titled, Nursing Clinical .Controlled
Medications-Storage, Reconciliation and Disposition, the P&P indicated, .Controlled Drugs that have been
discontinued shall be given to the Director of Nursing and must be secured in a double locked
container/space until disposed .Controlled medications remaining in the facility after the order has been
discontinued are retained in the facility in a securely locked area with restricted access until destroyed by a
DEA representative; destroyed by the facility's DNS or authorized designee, and consultant pharmacist .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555871
If continuation sheet
Page 2 of 2